Warning Letter

Key facts

Procedures

FDA Regulatory Procedures Manual, Chapter 4

Legal status

Informal and advisory; FDA does not treat it as final agency action

Typical response window

15 working days

Publication

Posted on the FDA website with confidential information redacted

Closure

Close-out letter after FDA confirms corrections

What is a Warning Letter?

A Warning Letter is the principal tool the Food and Drug Administration (FDA) uses to achieve voluntary compliance before going to court. It states the violations the agency found, cites the laws or regulations involved, and asks the recipient to explain in writing how and when it will correct them.

FDA issues Warning Letters only for violations of regulatory significance, meaning violations that may lead to enforcement action if not promptly and adequately corrected. The letter is informal and advisory: it communicates the position of the agency but does not commit FDA to taking enforcement action.

Recipients range widely, including drug and device manufacturers, compounding pharmacies, clinical investigators, online sellers making unapproved health claims, food firms and tobacco retailers.

How Warning Letters work

A Warning Letter typically follows this path:

Untitled letters are a lower tier. They address violations that do not meet the threshold for a Warning Letter and are common in advertising and promotion oversight by the FDA Office of Prescription Drug Promotion (OPDP).

• Trigger: often an inspection that ended with a Form 483 and an Official Action Indicated classification, but also reviews of websites, promotional materials, product samples or records.
• Content: specific violations, often describing products as adulterated or misbranded, and a request for a written response, typically within 15 working days.
• Consequences while open: FDA may withhold approval of pending applications that depend on the cited facility, decline export certificates, or place products on import alert.
• Closure: when FDA verifies corrections, often through reinspection, it can issue a close-out letter.

Why Warning Letters matter

Warning Letters are public, dated and specific, which makes them useful signals:

• Supply and sourcing risk: a Warning Letter at a manufacturing site is a leading indicator of delays, recalls or shortages for the products made there.
• Approval risk: sponsors relying on a cited facility may see pending approvals held until the issues are resolved.
• Promotional compliance: letters about misleading advertising show where FDA draws lines on claims.
• Deal screening: an open Warning Letter is a standard red flag in due diligence on manufacturers, contract manufacturers and consumer health brands.